Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (531-540 of 662) with videos related to

Pageof 67
Sort By:
Blood|January 18, 2013
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosisJason Gotlib, Animesh Pardanani, Cem Akin, et al.
Frontiers in Pharmacology|February 11, 2021
miRNome profiling of LSC-enriched CD34<sup>+</sup>CD38<sup>-</sup>CD26<sup>+</sup> fraction in Ph<sup>+</sup> CML-CP samples from Argentinean patients: a potential new pharmacogenomic toolMaría Sol Ruiz, María Belén Sánchez, Simone Bonecker, et al.
The Journal of Investigative Dermatology|July 8, 2014
Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitisSrinita Banerjee, Yvonne Resch, Kuan-Wei Chen, et al.
Oncotarget|February 15, 2011
Standards and impact of hematopathology in myelodysplastic syndromes (MDS)Peter Valent, Attilio Orazi, Guntram Büsche, et al.
Nature|August 5, 2011
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaJohannes Zuber, Junwei Shi, Eric Wang, et al.
Blood|March 29, 2014
A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfectionRosine Saleh, Ghaith Wedeh, Harald Herrmann, et al.
Leukemia Research|July 25, 2025
Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control studyAndreas Reiter, Jason Gotlib, Iván Álvarez-Twose, et al.
Expert Review of Hematology|April 6, 2012
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the fieldPeter Valent, Gerald J Gleich, Andreas Reiter, et al.
Hematological Oncology|April 3, 2022
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignanciesTariq I Mughal, Naveen Pemmaraju, Rafael Bejar, et al.
Leukemia|March 13, 2024
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines CommitteeDonal P McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Pageof 67

Showing results (531-540 of 662) with videos related to

Sort By:
Pageof 67
Blood|January 18, 2013
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosisJason Gotlib, Animesh Pardanani, Cem Akin, et al.
Frontiers in Pharmacology|February 11, 2021
miRNome profiling of LSC-enriched CD34<sup>+</sup>CD38<sup>-</sup>CD26<sup>+</sup> fraction in Ph<sup>+</sup> CML-CP samples from Argentinean patients: a potential new pharmacogenomic toolMaría Sol Ruiz, María Belén Sánchez, Simone Bonecker, et al.
The Journal of Investigative Dermatology|July 8, 2014
Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitisSrinita Banerjee, Yvonne Resch, Kuan-Wei Chen, et al.
Oncotarget|February 15, 2011
Standards and impact of hematopathology in myelodysplastic syndromes (MDS)Peter Valent, Attilio Orazi, Guntram Büsche, et al.
Nature|August 5, 2011
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaJohannes Zuber, Junwei Shi, Eric Wang, et al.
Blood|March 29, 2014
A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfectionRosine Saleh, Ghaith Wedeh, Harald Herrmann, et al.
Leukemia Research|July 25, 2025
Avapritinib versus midostaurin or cladribine in advanced systemic mastocytosis: A retrospective real-world external control studyAndreas Reiter, Jason Gotlib, Iván Álvarez-Twose, et al.
Expert Review of Hematology|April 6, 2012
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the fieldPeter Valent, Gerald J Gleich, Andreas Reiter, et al.
Hematological Oncology|April 3, 2022
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignanciesTariq I Mughal, Naveen Pemmaraju, Rafael Bejar, et al.
Leukemia|March 13, 2024
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines CommitteeDonal P McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Pageof 67